Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome.

Fecha de publicación: Fecha Ahead of Print:

Autores de IDIVAL

Autores ajenos al IDIVAL

  • Magaz M
  • Giudicelli-Lett H
  • G Abraldes J
  • Nicoara-Farcau O
  • Turon F
  • Rajoriya N
  • Goel A
  • Raymenants K
  • Hillaire S
  • Téllez L
  • Elkrief L
  • Procopet B
  • Orts L
  • Nery F
  • Shukla A
  • Larrue H
  • Degroote H
  • Aguilera V
  • LLop E
  • Turco L
  • Indulti F
  • Gioia S
  • Tosetti G
  • Bitto N
  • Becchetti C
  • Alvarado E
  • Roig C
  • Diaz R
  • Praktiknjo M
  • Konicek AL
  • Olivas P
  • Masnou H
  • Ardèvol A
  • Navascués CA
  • Romero-Gutiérrez M
  • Scheiner B
  • Semmler G
  • Mandorfer M
  • Damião F
  • Baiges A
  • Ojeda A
  • Simón-Talero M
  • González-Alayón C
  • Díaz A
  • García-Criado Á
  • De Gottardi A
  • Hernández-Guerra M
  • Genescà J
  • Drilhon N
  • Ferreira CN
  • Reiberger T
  • Rodríguez M
  • Morillas RM
  • Trebicka J
  • Bañares R
  • Villanueva C
  • Berzigotti A
  • Primignani M
  • La Mura V
  • Riggio O
  • Schepis F
  • Verhelst X
  • Calleja JL
  • Bureau C
  • Albillos A
  • Nevens F
  • Hernández-Gea V
  • Tripathi D
  • Rautou PE
  • García-Pagán JC
  • ERN RARE-LIVER; a study of VALDIG, an EASL consortium

Abstract

BACKGROUND & AIMS: Current knowledge of the natural history of patients with porto-sinusoidal vascular disorder (PSVD) is derived from small studies. The aim of the present study was to determine natural history and prognostic factors using a large multicenter cohort of PSVD patients. METHODS: Retrospective multicentric study of PSVD patients and signs of portal hypertension (PH) prospectively registered in 27 centers. RESULTS: 587 patients were included, median age of 47 years and 38% were women. Four-hundred and one patient had an associated condition, that was graded as severe in 157. Median follow-up was 68 months. At diagnosis, 64% of patients were asymptomatic while 36% had a PH-related complication: PH-related bleeding in 112 patients; ascites in 117 and hepatic encephalopathy in 11. In those not presenting with bleeding, the incidence of first bleeding was of 15% at 5 years, with a 5-year rebleeding rate of 18%. Five-year cumulative incidence of new or worsening ascites was of 18% and of developing PVT of 16%. Fifty (8.5%) patients received a liver transplantation and 109 (19%) died, including 55 non-liver related death. Transplant-free survival was 97%, and 83% at 1 and 5 years. Variables independently associated with transplant-free survival were age, ascites, serum bilirubin, albumin and creatinine levels at diagnosis and severe associated conditions. This allowed the creation of a Nomogram that accurately predicted prognosis. CONCLUSIONS: Prognosis of PSVD is strongly determined by the severity of the associated underlying conditions and parameters of liver and renal function.

Copyright © 2024 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Datos de la publicación

ISSN/ISSNe:
0168-8278, 1600-0641

JOURNAL OF HEPATOLOGY  ELSEVIER SCIENCE BV

Tipo:
Article
Páginas:
72-83

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Porto-sinusoidal vascular disorder; idiopathic portal hypertension; natural history

Compartir